Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenisept in chronic leg ulcers
NCT01434914Phase 4Terminated
- Sponsor
- Schülke & Mayr
- Start
- Oct 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of octenidine dihydrochloride + phenoxyethanol in venous leg ulcer (VLU), sponsored by Schülke & Mayr. Started Oct 2011; status: terminated.
02
Drugs
octenidine dihydrochloride + phenoxyethanol
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT01434914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01434914.